BAP1 Immunocytochemistry and BAP1 and p16 Fluorescence In-Situ Hybridization for the Diagnosis of Malignant Mesothelioma in Effusion Samples

被引：0
|
作者：
Agrawal, Tanupriya [1 ]
Fetsch, Patricia [1 ]
Abdullaev, Zied [2 ]
Skarshaug, Shannon [1 ]
Zgonc, Valerie [1 ]
Roth, Mark [1 ]
Pack, Svetlana D. [2 ]
Hassan, Raffit [1 ]
Filie, Armando [1 ]
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
357
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [1] BAP1 Immunocytochemistry and BAP1 and p16 Fluorescence In-Situ Hybridization for the Diagnosis of Malignant Mesothelioma in Effusion Samples
    Agrawal, Tanupriya
    Fetsch, Patricia
    Abdullaev, Zied
    Skarshaug, Shannon
    Zgonc, Valerie
    Roth, Mark
    Pack, Svetlana D.
    Hassan, Raffit
    Filie, Armando
    LABORATORY INVESTIGATION, 2018, 98 : 129 - 129
  • [2] Role of p16 deletion and BAP1 loss in the diagnosis of malignant mesothelioma
    Liu, Jing
    Liao, Xuanzhi
    Gu, Yingying
    Fu, Lin
    Zhao, Jin
    Li, Longguang
    Chen, Zhucheng
    Jiang, Juhong
    JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5522 - 5530
  • [3] BAP1 immunohistochemistry and p16 FISH in the diagnosis of malignant peritoneal mesothelioma
    Kawai, T.
    Kameda, K.
    Nakanishi, K.
    Hiroshima, K.
    VIRCHOWS ARCHIV, 2016, 469 : S91 - S91
  • [4] Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma
    Wu, Di
    Hiroshima, Kenzo
    Yusa, Toshikazu
    Ozaki, Daisuke
    Koh, Eitetsu
    Sekine, Yasuo
    Matsumoto, Shinji
    Nabeshima, Kazuki
    Sato, Ayuko
    Tsujimura, Tohru
    Yamakawa, Hisami
    Tada, Yuji
    Shimada, Hideaki
    Tagawa, Masatoshi
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 26 : 31 - 37
  • [5] FISH Analysis of p16 and BAP1 Immunohistochemistry for the Diagnosis of Mesothelioma
    Hiroshima, K.
    Wu, D.
    Yusa, T.
    Ozaki, D.
    Koh, E.
    Sekine, Y.
    Haba, R.
    Washimi, K.
    Nabeshima, K.
    Tsujimura, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2157 - S2158
  • [6] Combined Use of p16 FISH and Bap1 Immunohistochemistry Optimizes Diagnosis of Malignant Pleural Mesothelioma
    McGregor, S. M.
    Minor, A.
    Fitzpatrick, C.
    Husain, A. N.
    Hyjek, E.
    Vigneswaran, W.
    Krausz, T.
    MODERN PATHOLOGY, 2013, 26 : 460A - 460A
  • [7] Combined Use of p16 FISH and Bap1 Immunohistochemistry Optimizes Diagnosis of Malignant Pleural Mesothelioma
    McGregor, S. M.
    Minor, A.
    Fitzpatrick, C.
    Husain, A. N.
    Hyjek, E.
    Vigneswaran, W.
    Krausz, T.
    LABORATORY INVESTIGATION, 2013, 93 : 460A - 460A
  • [8] BAP1 mutation in mesothelioma and "BAP1 Cancer Syndrome"
    Nasu, Masaki
    Napolitano, Andrea
    Pastorino, Sandra
    Tanji, Mika
    Flores, Erin
    Baumann, Francine
    Powers, Amy
    Gaudino, Giovanni
    Pass, Harvey I.
    Yang, Haining
    Carbone, Michele
    CANCER RESEARCH, 2014, 74 (19)
  • [9] Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens
    Hwang, Harry C.
    Sheffield, Brandon S.
    Rodriguez, Stephanie
    Thompson, Kim
    Tse, Christopher H.
    Gown, Allen M.
    Churg, Andrew
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (01) : 120 - 126
  • [10] BAP1 Immunostain and P16 FISH: Clinical Applicability to Confirm Malignant Mesothelioma in Effusions
    Walts, Ann E.
    Hiroshima, Kenzo
    McGregor, Stephanie
    Husain, Aliya N.
    Marchevsky, Alberto M.
    MODERN PATHOLOGY, 2016, 29 : 486A - 486A
12345